IFNA1 and depressive disorder: In addition, IFN-α and IFB-β can activate μ opioid receptor, which increases prostaglandin E2 levels in brain, in turn increases the indoleamine-2,3-dioxygenase (IDO) pathway, which leads to neurotoxicity, finally develops depression [48,55].